Correlation Between Cadrenal Therapeutics, and Fortress Biotech
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Fortress Biotech Pref, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Fortress Biotech.
Diversification Opportunities for Cadrenal Therapeutics, and Fortress Biotech
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cadrenal and Fortress is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Fortress Biotech Pref in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech Pref and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech Pref has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Fortress Biotech go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Fortress Biotech
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 2.86 times more return on investment than Fortress Biotech. However, Cadrenal Therapeutics, is 2.86 times more volatile than Fortress Biotech Pref. It trades about -0.07 of its potential returns per unit of risk. Fortress Biotech Pref is currently generating about -0.26 per unit of risk. If you would invest 1,639 in Cadrenal Therapeutics, Common on August 31, 2024 and sell it today you would lose (224.00) from holding Cadrenal Therapeutics, Common or give up 13.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Fortress Biotech Pref
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Fortress Biotech Pref |
Cadrenal Therapeutics, and Fortress Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Fortress Biotech
The main advantage of trading using opposite Cadrenal Therapeutics, and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.| Cadrenal Therapeutics, vs. Cue Biopharma | Cadrenal Therapeutics, vs. Tff Pharmaceuticals | Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Inhibrx |
| Fortress Biotech vs. Absci Corp | Fortress Biotech vs. Larimar Therapeutics | Fortress Biotech vs. InMed Pharmaceuticals | Fortress Biotech vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |